ARCT, NGM
Arcturus Therapeutics Holdings Inc. (ARCT)
Price (as of October 25)
14.86USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
CureVac N.V. |
-0.32 |
|
Compass Therapeutics, Inc. |
-0.31 |
|
Ikena Oncology, Inc. |
-0.31 |
|
Corcept Therapeutics Incorporated |
-0.31 |
|
Corbus Pharmaceuticals Holdings, Inc. |
-0.28 |
|
Ampio Pharmaceuticals, Inc. |
0.06 |
|
Hepion Pharmaceuticals, Inc. |
-0.03 |
|
CTI BioPharma Corp. |
-0.01 |
|
Clearside Biomedical, Inc. |
-0.03 |
|
Concert Pharmaceuticals, Inc. |
-0.02 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.85 |
|
Atara Biotherapeutics, Inc. |
0.78 |
|
Ardelyx, Inc. |
0.76 |
|
Arvinas, Inc. |
0.76 |
|
Atai Life Sciences N.V. |
0.73 |
|
Ascendis Pharma A/S |
0.14 |
|
Arcutis Biotherapeutics, Inc. |
0.18 |
|
AnaptysBio, Inc. |
0.09 |
|
Allogene Therapeutics, Inc. |
0.24 |
|
Artelo Biosciences, Inc. |
0.1 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.18 |
|
Ikena Oncology, Inc. |
-0.17 |
|
Acurx Pharmaceuticals, Inc. |
-0.15 |
|
Halozyme Therapeutics, Inc. |
-0.14 |
|
Forward Pharma A/S |
-0.14 |
|
Clearside Biomedical, Inc. |
-0.03 |
|
Corcept Therapeutics Incorporated |
-0.01 |
|
Corbus Pharmaceuticals Holdings, Inc. |
-0.02 |
|
Acer Therapeutics Inc. |
0.02 |
|
Hepion Pharmaceuticals, Inc. |
-0.03 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.59 |
|
Allogene Therapeutics, Inc. |
0.58 |
|
ALX Oncology Holdings Inc. |
0.54 |
|
Atara Biotherapeutics, Inc. |
0.53 |
|
Arcutis Biotherapeutics, Inc. |
0.5 |
|
AnaptysBio, Inc. |
0.09 |
|
Arvinas, Inc. |
0.18 |
|
AlloVir, Inc. |
0.3 |
|
Applied Molecular Transport Inc. |
0.23 |
|
Alpine Immune Sciences, Inc. |
0.14 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.18 |
|
Ikena Oncology, Inc. |
-0.1 |
|
Acurx Pharmaceuticals, Inc. |
-0.08 |
|
AIkido Pharma Inc. |
-0.07 |
|
Bright Minds Biosciences Inc. |
-0.06 |
|
Concert Pharmaceuticals, Inc. |
-0.02 |
|
ImmunityBio, Inc. |
-0.05 |
|
Gain Therapeutics, Inc. |
-0.05 |
|
CRISPR Therapeutics AG |
-0.04 |
|
Achilles Therapeutics plc |
-0.05 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.4 |
|
AlloVir, Inc. |
0.3 |
|
ALX Oncology Holdings Inc. |
0.26 |
|
Amylyx Pharmaceuticals, Inc. |
0.26 |
|
Allogene Therapeutics, Inc. |
0.24 |
|
Allarity Therapeutics, Inc. |
0.24 |
|
Applied Molecular Transport Inc. |
0.23 |
|
Actinium Pharmaceuticals, Inc. |
0.18 |
|
Alnylam Pharmaceuticals, Inc. |
0.18 |
|
Arrowhead Pharmaceuticals, Inc. |
0.13 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.18 |
|
Ikena Oncology, Inc. |
-0.1 |
|
Acurx Pharmaceuticals, Inc. |
-0.08 |
|
Bright Minds Biosciences Inc. |
-0.06 |
|
Gain Therapeutics, Inc. |
-0.05 |
|
ImmunityBio, Inc. |
-0.05 |
|
Achilles Therapeutics plc |
-0.05 |
|
Entasis Therapeutics Holdings Inc. |
-0.05 |
|
BioAtla, Inc. |
-0.05 |
|
Aerovate Therapeutics, Inc. |
-0.04 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.4 |
|
AlloVir, Inc. |
0.3 |
|
ALX Oncology Holdings Inc. |
0.26 |
|
Amylyx Pharmaceuticals, Inc. |
0.26 |
|
Allogene Therapeutics, Inc. |
0.24 |
|
Allarity Therapeutics, Inc. |
0.24 |
|
Applied Molecular Transport Inc. |
0.23 |
|
Ambrx Biopharma Inc. |
0.21 |
|
Alzamend Neuro, Inc. |
0.21 |
|
Atara Biotherapeutics, Inc. |
0.18 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
CureVac N.V. |
-0.32 |
|
Compass Therapeutics, Inc. |
-0.31 |
|
Ikena Oncology, Inc. |
-0.31 |
|
Corcept Therapeutics Incorporated |
-0.31 |
|
Corbus Pharmaceuticals Holdings, Inc. |
-0.28 |
|
DocGo Inc. |
-0.09 |
|
Clever Leaves Holdings Inc. |
0.01 |
|
Ampio Pharmaceuticals, Inc. |
0.06 |
|
Delcath Systems, Inc. |
0.01 |
|
Genetic Technologies Limited |
0.01 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.85 |
|
Atara Biotherapeutics, Inc. |
0.78 |
|
Ardelyx, Inc. |
0.76 |
|
Arvinas, Inc. |
0.76 |
|
Atai Life Sciences N.V. |
0.73 |
|
Ascendis Pharma A/S |
0.14 |
|
Arcutis Biotherapeutics, Inc. |
0.18 |
|
Alphatec Holdings, Inc. |
0.08 |
|
Asensus Surgical, Inc. |
0.11 |
|
AnaptysBio, Inc. |
0.09 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.18 |
|
Ikena Oncology, Inc. |
-0.17 |
|
Acurx Pharmaceuticals, Inc. |
-0.15 |
|
Halozyme Therapeutics, Inc. |
-0.14 |
|
Forward Pharma A/S |
-0.14 |
|
Clearside Biomedical, Inc. |
-0.03 |
|
Corcept Therapeutics Incorporated |
-0.01 |
|
Corbus Pharmaceuticals Holdings, Inc. |
-0.02 |
|
CareMax, Inc. |
-0.05 |
|
Acer Therapeutics Inc. |
0.02 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.59 |
|
Allogene Therapeutics, Inc. |
0.58 |
|
ALX Oncology Holdings Inc. |
0.54 |
|
Atara Biotherapeutics, Inc. |
0.53 |
|
Arcutis Biotherapeutics, Inc. |
0.5 |
|
American Well Corporation |
0.3 |
|
AnaptysBio, Inc. |
0.09 |
|
Arvinas, Inc. |
0.18 |
|
AlloVir, Inc. |
0.3 |
|
Applied Molecular Transport Inc. |
0.23 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.18 |
|
Ikena Oncology, Inc. |
-0.1 |
|
DocGo Inc. |
-0.09 |
|
Acurx Pharmaceuticals, Inc. |
-0.08 |
|
Field Trip Health Ltd. |
-0.07 |
|
Harvard Bioscience, Inc. |
-0.04 |
|
AIkido Pharma Inc. |
-0.04 |
|
Bright Minds Biosciences Inc. |
-0.06 |
|
Concert Pharmaceuticals, Inc. |
-0.02 |
|
ImmunityBio, Inc. |
-0.05 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.4 |
|
AlloVir, Inc. |
0.3 |
|
American Well Corporation |
0.3 |
|
ALX Oncology Holdings Inc. |
0.26 |
|
Amylyx Pharmaceuticals, Inc. |
0.26 |
|
Allogene Therapeutics, Inc. |
0.24 |
|
Allarity Therapeutics, Inc. |
0.24 |
|
Applied Molecular Transport Inc. |
0.23 |
|
Actinium Pharmaceuticals, Inc. |
0.18 |
|
Alnylam Pharmaceuticals, Inc. |
0.18 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Arcellx, Inc. |
-0.18 |
|
Ikena Oncology, Inc. |
-0.1 |
|
DocGo Inc. |
-0.09 |
|
Acurx Pharmaceuticals, Inc. |
-0.08 |
|
Field Trip Health Ltd. |
-0.07 |
|
Bright Minds Biosciences Inc. |
-0.06 |
|
CareMax, Inc. |
-0.05 |
|
Gain Therapeutics, Inc. |
-0.05 |
|
ImmunityBio, Inc. |
-0.05 |
|
Achilles Therapeutics plc |
-0.05 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.4 |
|
AlloVir, Inc. |
0.3 |
|
American Well Corporation |
0.3 |
|
ALX Oncology Holdings Inc. |
0.26 |
|
Amylyx Pharmaceuticals, Inc. |
0.26 |
|
Allogene Therapeutics, Inc. |
0.24 |
|
Allarity Therapeutics, Inc. |
0.24 |
|
Applied Molecular Transport Inc. |
0.23 |
|
Ambrx Biopharma Inc. |
0.21 |
|
Alzamend Neuro, Inc. |
0.21 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
German American Bancorp, Inc. |
-0.41 |
|
Canadian Solar Inc. |
-0.38 |
|
Gores Holdings IX, Inc. |
-0.33 |
|
Concord Acquisition Corp II |
-0.32 |
|
CureVac N.V. |
-0.32 |
|
FTAC Parnassus Acquisition Corp. |
-0.07 |
|
CompoSecure, Inc. |
-0.06 |
|
Compass Therapeutics, Inc. |
0.02 |
|
Ikena Oncology, Inc. |
-0.1 |
|
DIRTT Environmental Solutions Ltd. |
0 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.85 |
|
ARK Genomic Revolution ETF |
0.85 |
|
ARK Autonomous Technology & Robotics ETF |
0.79 |
|
ARK Space Exploration & Innovation ETF |
0.78 |
|
Atara Biotherapeutics, Inc. |
0.78 |
|
Ardelyx, Inc. |
0.09 |
|
Arvinas, Inc. |
0.18 |
|
Atai Life Sciences N.V. |
0.4 |
|
Arrival |
0.4 |
|
Atlanticus Holdings Corporation |
0.1 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Gores Holdings IX, Inc. |
-0.32 |
|
Dakota Gold Corp. |
-0.23 |
|
1stdibs.Com, Inc. |
-0.21 |
|
Excelerate Energy, Inc. |
-0.21 |
|
First Merchants Corporation |
-0.21 |
|
Empowerment & Inclusion Capital I Corp. |
-0.07 |
|
Ebix, Inc. |
-0.03 |
|
Arcellx, Inc. |
-0.18 |
|
Catalyst Bancorp, Inc. |
-0.18 |
|
Optica Rare Earths & Critical Materials ETF |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Genomic Revolution ETF |
0.66 |
|
Arrowhead Pharmaceuticals, Inc. |
0.59 |
|
ARK Autonomous Technology & Robotics ETF |
0.59 |
|
Allogene Therapeutics, Inc. |
0.58 |
|
ARK Space Exploration & Innovation ETF |
0.56 |
|
ALX Oncology Holdings Inc. |
0.26 |
|
Alkami Technology, Inc. |
0.42 |
|
Atara Biotherapeutics, Inc. |
0.18 |
|
Affiliated Managers Group, Inc. |
0.15 |
|
Arcutis Biotherapeutics, Inc. |
0.18 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Gores Holdings IX, Inc. |
-0.32 |
|
Dakota Gold Corp. |
-0.23 |
|
Edoc Acquisition Corp. |
-0.22 |
|
Excelerate Energy, Inc. |
-0.21 |
|
First Merchants Corporation |
-0.21 |
|
1stdibs.Com, Inc. |
-0.2 |
|
Arcellx, Inc. |
-0.18 |
|
Catalyst Bancorp, Inc. |
-0.18 |
|
Optica Rare Earths & Critical Materials ETF |
-0.18 |
|
Consilium Acquisition Corp I, Ltd. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Space Exploration & Innovation ETF |
0.55 |
|
ARK Genomic Revolution ETF |
0.47 |
|
Alkami Technology, Inc. |
0.42 |
|
Arhaus, Inc. |
0.4 |
|
Arrival |
0.4 |
|
Atai Life Sciences N.V. |
0.4 |
|
RH Hedged Multi-Asset Income ETF |
0.31 |
|
ARK Autonomous Technology & Robotics ETF |
0.24 |
|
Amplitude, Inc. |
0.31 |
|
AlloVir, Inc. |
0.3 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Gores Holdings IX, Inc. |
-0.32 |
|
Dakota Gold Corp. |
-0.23 |
|
Edoc Acquisition Corp. |
-0.22 |
|
Excelerate Energy, Inc. |
-0.21 |
|
First Merchants Corporation |
-0.21 |
|
1stdibs.Com, Inc. |
-0.2 |
|
Arcellx, Inc. |
-0.18 |
|
Catalyst Bancorp, Inc. |
-0.18 |
|
Optica Rare Earths & Critical Materials ETF |
-0.18 |
|
Consilium Acquisition Corp I, Ltd. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Space Exploration & Innovation ETF |
0.55 |
|
Alkami Technology, Inc. |
0.42 |
|
ARK Genomic Revolution ETF |
0.42 |
|
Arhaus, Inc. |
0.4 |
|
Arrival |
0.4 |
|
Atai Life Sciences N.V. |
0.4 |
|
RH Hedged Multi-Asset Income ETF |
0.31 |
|
Amplitude, Inc. |
0.31 |
|
AlloVir, Inc. |
0.3 |
|
American Well Corporation |
0.3 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company’s development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California.